Literature DB >> 34362465

RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours.

Fei Xu1,2, Lixin Na2,3, Yanfei Li3, Linjun Chen4.   

Abstract

The PI3 K/AKT/mTOR signalling pathway plays an important role in the regulation of signal transduction and biological processes such as cell proliferation, apoptosis, metabolism and angiogenesis. Compared with those of other signalling pathways, the components of the PI3K/AKT/mTOR signalling pathway are complicated. The regulatory mechanisms and biological functions of the PI3K/AKT/mTOR signalling pathway are important in many human diseases, including ischaemic brain injury, neurodegenerative diseases, and tumours. PI3K/AKT/mTOR signalling pathway inhibitors include single-component and dual inhibitors. Numerous PI3K inhibitors have exhibited good results in preclinical studies, and some have been clinically tested in haematologic malignancies and solid tumours. In this review, we briefly summarize the results of research on the PI3K/AKT/mTOR pathway and discuss the structural composition, activation, communication processes, regulatory mechanisms and biological functions of the PI3K/AKT/mTOR signalling pathway in the pathogenesis of neurodegenerative diseases and tumours.
© 2020. The Author(s).

Keywords:  Ischaemic brain injury; Neurodegenerative diseases; PI3K/AKT/mTOR signalling pathway; Regulatory mechanism; Tumour

Year:  2020        PMID: 34362465     DOI: 10.1186/s13578-020-00416-0

Source DB:  PubMed          Journal:  Cell Biosci        ISSN: 2045-3701            Impact factor:   7.133


  105 in total

Review 1.  [Reaserch Advances on the Role of PI3K/AKT Signaling Pathway and MiRNA in Acute T-Cell Lymphocytic Leukemia--Review].

Authors:  Yong-Jun Li; Xiao-Fei Li; Er-Huan Yang; Min Shi
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2019-08

Review 2.  PI3k/AKT signaling pathway: Erythropoiesis and beyond.

Authors:  Mahjoobeh Jafari; Elham Ghadami; Tahereh Dadkhah; Haleh Akhavan-Niaki
Journal:  J Cell Physiol       Date:  2018-09-07       Impact factor: 6.384

Review 3.  Emerging role of PI3K/AKT in tumor-related epigenetic regulation.

Authors:  Qi Yang; Wei Jiang; Peng Hou
Journal:  Semin Cancer Biol       Date:  2019-04-02       Impact factor: 15.707

Review 4.  The role of PI3K/AKT/FOXO signaling in psoriasis.

Authors:  Miao Zhang; Xiaoyan Zhang
Journal:  Arch Dermatol Res       Date:  2018-11-27       Impact factor: 3.017

Review 5.  The Role of PI3K/Akt and ERK in Neurodegenerative Disorders.

Authors:  Sachchida Nand Rai; Hagera Dilnashin; Hareram Birla; Saumitra Sen Singh; Walia Zahra; Aaina Singh Rathore; Brijesh Kumar Singh; Surya Pratap Singh
Journal:  Neurotox Res       Date:  2019-02-01       Impact factor: 3.911

Review 6.  Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: a review.

Authors:  Siti Muhamad Nur Husna; Hern-Tze Tina Tan; Rohimah Mohamud; Anne Dyhl-Polk; Kah Keng Wong
Journal:  Ther Adv Med Oncol       Date:  2018-11-09       Impact factor: 8.168

Review 7.  The PI3K/AKT pathway in obesity and type 2 diabetes.

Authors:  Xingjun Huang; Guihua Liu; Jiao Guo; Zhengquan Su
Journal:  Int J Biol Sci       Date:  2018-08-06       Impact factor: 6.580

Review 8.  PI3K Signaling in Neurons: A Central Node for the Control of Multiple Functions.

Authors:  Karina Sánchez-Alegría; Manuel Flores-León; Evangelina Avila-Muñoz; Nelly Rodríguez-Corona; Clorinda Arias
Journal:  Int J Mol Sci       Date:  2018-11-23       Impact factor: 5.923

Review 9.  Roles of PI3K/AKT/GSK3 Pathway Involved in Psychiatric Illnesses.

Authors:  Satoru Matsuda; Yuka Ikeda; Mutsumi Murakami; Yukie Nakagawa; Ai Tsuji; Yasuko Kitagishi
Journal:  Diseases       Date:  2019-02-13

Review 10.  PI3K isoforms in cell signalling and vesicle trafficking.

Authors:  Benoit Bilanges; York Posor; Bart Vanhaesebroeck
Journal:  Nat Rev Mol Cell Biol       Date:  2019-09       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.